Lyra Therapeutics, Inc.LYRANASDAQ
Loading
Debt Growth Under PressureDecelerating
Percentile Rank54
Year-over-Year Change
Year-over-year debt growth rate
Percentile
P54
Within normal range
vs 2Y Ago
0x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | -3.38% |
| Q2 2025 | -2.63% |
| Q1 2025 | -2.98% |
| Q4 2024 | -2.67% |
| Q3 2024 | -3.88% |
| Q2 2024 | -2.94% |
| Q1 2024 | 40.84% |
| Q4 2023 | 327.36% |
| Q3 2023 | 272.63% |
| Q2 2023 | -19.27% |
| Q1 2023 | -49.94% |
| Q4 2022 | 535.77% |
| Q3 2022 | -29.28% |
| Q2 2022 | -22.32% |
| Q1 2022 | -17.69% |
| Q4 2021 | -14.93% |
| Q3 2021 | -12.77% |
| Q2 2021 | -11.12% |
| Q1 2021 | -9.68% |
| Q4 2020 | -8.72% |
| Q3 2020 | -7.89% |
| Q2 2020 | -6.75% |
| Q1 2020 | -6.46% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |